Hypercholesterolemia and cardiovascular disease: Focus on high cardiovascular risk patients
Open Access
- 1 December 2020
- journal article
- research article
- Published by Elsevier BV in Atherosclerosis Supplements
- Vol. 42, e30-e34
- https://doi.org/10.1016/j.atherosclerosissup.2021.01.006
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Screening for Familial Hypercholesterolemia in Children: What Can We Learn From Adult Screening Programs?Healthcare, 2015
- ODYSSEY FH I and FH II: 78 week results with alirocumab treatment in 735 patients with heterozygous familial hypercholesterolaemiaEuropean Heart Journal, 2015
- Ezetimibe Added to Statin Therapy after Acute Coronary SyndromesThe New England Journal of Medicine, 2015
- Familial hypercholesterolaemia in children and adolescents: gaining decades of life by optimizing detection and treatmentEuropean Heart Journal, 2015
- Aligning Policy to Promote Cascade Genetic Screening for Prevention and Early Diagnosis of Heritable DiseasesJournal of Genetic Counseling, 2015
- PCSK9 inhibition with evolocumab (AMG 145) in heterozygous familial hypercholesterolaemia (RUTHERFORD-2): a randomised, double-blind, placebo-controlled trialThe Lancet, 2014
- Inhibition of PCSK9 with evolocumab in homozygous familial hypercholesterolaemia (TESLA Part B): a randomised, double-blind, placebo-controlled trialThe Lancet, 2014
- Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: Consensus Statement of the European Atherosclerosis SocietyEuropean Heart Journal, 2013
- Attainment of optional low-density lipoprotein cholesterol goal of less than 70 mg/dl and impact on prognosis of very high risk stable coronary patients: a 3-year follow-upExpert Opinion on Pharmacotherapy, 2011
- Child-parent screening for familial hypercholesterolaemia: screening strategy based on a meta-analysisBMJ, 2007